TGen News & Press Releases

TGen-ASU study identifies molecular response of muscle to different types of exercise

Posted Tuesday March 20, 2018

Hundreds of genes are affected; different types of exercises affect unique sets of genes

TGen tests ultrasound as way to enhance cancer drug delivery

Posted Monday March 19, 2018

Sound waves drive drug therapies to cancer cells; minimize toxicity

Destroy Pancreatic Cancer dedicates $1 million for unique TGen-designed clinical trial

Posted Monday March 12, 2018

Non-profit created by cancer survivors aims for better treatments at Atlanta’s Piedmont Cancer Institute

Wendy’s Puts the Freeze on Cancer with Jr. Frosty

Posted Monday March 5, 2018

$1 donation for 5 free Jr. Frosty coupons adds dollars for TGen cancer research

TGen-led study finds potent anti-cancer drug effect in rare ovarian cancer

Posted Thursday March 1, 2018

Ponatinib is effective against SCCOHT, a type of ovarian cancer that mostly strikes young women and girls as young as 14 months

How did a deadly tropical fungus get to the temperate environs of the Pacific Northwest?

Posted Wednesday January 17, 2018

TGen-led study points to opening of the Panama Canal as the gateway of pathogen migration from Brazil to Canada

Barrett-Jackson will auction beautifully restored Monte Carlo SS to benefit TGen cancer research

Posted Wednesday January 10, 2018

First ‘Project Prestone’ resto-mod will cross the auction block Jan. 18 at WestWorld of Scottsdale

Applications open today for first class of TGen Bioscience Leadership Academy

Posted Wednesday January 3, 2018

New high school program joins successful Helios Scholars at TGen in preparing Arizona students for high-tech biomedical careers

Baylor Scott & White Research Institute and TGen poised to create early detection test for pancreatic cancer

Posted Monday December 11, 2017

$5.13 million National Cancer Institute grant funds research to help identify patients before the disease causes symptoms or spreads

DxNA LLC receives a de novo regulatory clearance by the FDA for the GeneSTAT.MDx™ Coccidioides Test on the GeneSTAT® Analyzer - the only FDA cleared molecular test for Valley Fever

Posted Wednesday December 6, 2017

With technology developed by TGen, the test allows for rapid definitive diagnosis of Valley Fever.

Prev
1
2
[3]
4
5
Next

Search

Media Contact

Steve Yozwiak
[email protected]
602-343-8704

Newsletter

News Archive

View Media Release Archive